Ribociclib-Induced Vitiligo: A Case Report

Ribociclib-Induced Vitiligo: A Case Report

Authors

  • Nicolás Silvestre Torner Department of Dermatology, Hospital Universitario Severo Ochoa, Leganés (Madrid), Spain
  • Antonio Aguilar Martínez Department of Dermatology, Hospital Universitario Severo Ochoa, Leganés (Madrid), Spain
  • María José Echarri González Department of Oncology, Hospital Universitario Severo Ochoa, Leganés (Madrid), Spain
  • Sergio Tabbara Carrascosa Department of Dermatology, Hospital Universitario Severo Ochoa, Leganés (Madrid), Spain
  • Jorge Román Sainz Department of Dermatology, Hospital Universitario Severo Ochoa, Leganés (Madrid), Spain
  • Fernando Gruber Velasco Department of Dermatology, Hospital Universitario Severo Ochoa, Leganés (Madrid), Spain

Keywords:

vitiligo, ribociclib, selective cyclin-dependent kinase 4/6 inhibitors, breast cancer, adverse event

References

1. Rascon K, Flajc G, De Angelis C, Liu X, Trivedi MV, Ekinci E. Ribociclib in HR+/HER2- Advanced or Metastatic Breast Cancer Patients. Ann Pharmacother 2019;53:501–9. DOI: 10.1177/1060028018817904.
2. Sollena P, Nikolaou V, Soupos N, et al. Vitiligo-like lesions in patients with advanced breast cancer treated with cycline-dependent kinases 4 and 6 inhibitors. Breast Cancer Res Treat 2021;185(1):247-253. DOI: 10.1007/s10549-020-05914-w.

Downloads

Published

2022-05-02

Issue

2022 Vol 12, No 2 | April

Section

Research Letter

License

Copyright (c) 2022 Nicolás Silvestre Torner, Antonio Aguilar Martínez, María José Echarri González, Sergio Tabbara Carrascosa, Jorge Román Sainz, Fernando Gruber Velasco

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Dermatology Practical & Conceptual applies a Creative Commons Attribution License (CCAL) to all works we publish (http://creativecommons.org/licenses/by-nc/4.0/). Authors retain the copyright for their published work.

How to Cite

1.
Silvestre Torner N, Aguilar Martínez A, Echarri González MJ, Tabbara Carrascosa S, Román Sainz J, Gruber Velasco F. Ribociclib-Induced Vitiligo: A Case Report. Dermatol Pract Concept. 2022;12(2):e20220045. doi:10.5826/dpc.1202a45

Share

Crossref
Scopus
Google Scholar
Europe PMC